• 1
    Musselman DL, Nemeroff CB. Depression and endocrine disorders: Focus on the thyroid and adrenal system. Br. J. Psychiatry 1996; 123128.
  • 2
    Iga J, Taniguchi T, Ohmori T. Mood swing from severe depression to mania following acute alteration of thyroid status. Gen. Hosp. Psychiatry 2005; 27: 451453.
  • 3
    Whybrow PC, Prange AJ Jr. A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to affective illness. Arch. Gen. Psychiatry 1981; 38: 106113.
  • 4
    Henley WN, Koehnle TJ. Thyroid hormones and the treatment of depression: An examination of basic hormonal actions in the mature mammalian brain. Synapse 1997; 27: 3644.
  • 5
    Whybrow PC. The therapeutic use of triiodothyronine and high dose thyroxine in psychiatric disorder. Acta. Med. Austriaca 1994; 21: 4752.
  • 6
    Prange AJ Jr. Novel uses of thyroid hormones in patients with affective disorders. Thyroid 1996; 6: 537543.
  • 7
    Hickie I, Bennett B, Mitchell P, Wilhelm K, Orlay W. Clinical and subclinical hypothyroidism in patients with chronic and treatment-resistant depression. Aust. N. Z. J. Psychiatry 1996; 30: 246252.
  • 8
    Davis JD, Stern RA, Flashman LA. Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: Significance in the elderly. Curr. Psychiatry Rep. 2003; 5: 384390.
  • 9
    Marangell LB, Ketter TA, George MS et al. Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders. Am. J. Psychiatry 1997; 154: 224230.
  • 10
    Forman-Hoffman V, Philibert RA Lower TSH and higher T4 levels are associated with current depressive syndrome in young adults. Acta. Psychiatr. Scand. 2006; 114: 132139.
  • 11
    Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 2000; 160: 526534.
  • 12
    Urban RJ. Neuroendocrinology of aging in the male and female. Endocrinol. Metab. Clin. North Am. 1992; 21: 921931.
  • 13
    Erfurth EM, Ericsson UB. The role of estrogen in the TSH and prolactin responses to thyrotropin-releasing hormone in postmenopausal as compared to premenopausal women. Horm. Metab. Res. 1992; 24: 528531.
  • 14
    De Leo V, D'Antona D, Lanzetta D. Thyrotropin secretion before and after ovariectomy in premenopausal women. Gynecol. Endocrinol. 1993; 7: 279283.
  • 15
    Gokmen O, Seckin NC, Sener AB, Ozaksit G, Ekmekci S. A study of premature ovarian failure in Turkish women. Gynecol. Endocrinol. 1995; 9: 283287.
  • 16
    Abdalla HI, Beastall G, Fletcher D, Hawthorn JS, Smith J, Hart DM. Sex steroid replacement in post-menopausal women: Effects on thyroid hormone status. Maturitas 1987; 9: 4954.
  • 17
    Takatani O, Okumoto T, Kosano H, Nishida M, Hiraide H, Tamakuma S. Relationship between the levels of serum thyroid hormones or estrogen status and the risk of breast cancer genesis in Japanese women. Cancer Res. 1989; 49: 31093112.
  • 18
    Abech DD, Moratelli HB, Leite SC, Oliveira MC. Effects of estrogen replacement therapy on pituitary size, prolactin and thyroid-stimulating hormone concentrations in menopausal women. Gynecol. Endocrinol. 2005; 21: 223226.
  • 19
    Shah N, Evans WS, Veldhuis JD. Actions of estrogen on pulsatile, nyctohemeral, and entropic modes of growth hormone secretion. Am. J. Physiol. 1999; 276: R1351R1358.
  • 20
    Zidan J, Rubenstein W. Effect of adjuvant tamoxifen therapy on thyroid function in postmenopausal women with breast cancer. Oncology 1999; 56: 4345.
  • 21
    Parry BL, Meliska CJ, Martinez LF et al. Menopause: Neuroendocrine changes and hormone replacement therapy. J. Am. Med. Womens Assoc. 2004; 59: 135145.
  • 22
    Bottner M, Christoffel J, Rimoldi G, Wuttke W. Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on the pituitary-thyroid-axis. Exp. Clin. Endocrinol. Diabetes 2006; 114: 8290.
  • 23
    Benencia H, Ropelato MG, Rosales M et al. Thyroid profile modifications during oral hormone replacement therapy in postmenopausal women. Gynecol. Endocrinol. 1998; 12: 179184.
  • 24
    Hsu SH, Cheng WC, Jang MW, Tsai KS. Effects of long-term use of raloxifene, a selective estrogen receptor modulator, on thyroid function test profiles. Clin. Chem. 2001; 47: 18651867.
  • 25
    Duntas LH, Mantzou E, Koutras DA. Lack of substantial effects of raloxifene on thyroxine-binding globulin inpostmenopausal women: Dependency on thyroid status. Thyroid 2001; 11: 779782.
  • 26
    Abdalla HI, Hart DM, Beastall GH. Reduced serum free thyroxine concentration in postmenopausal women receiving oestrogen treatment. BMJ 1984; 288: 754755.
  • 27
    Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N. Engl. J. Med. 2001; 344: 17431749.
  • 28
    Marqusee E, Braverman LE, Lawrence JE, Carroll JS, Seely EW. The effect of droloxifene and estrogen on thyroid function in postmenopausal women. J. Clin. Endocrinol. Metab. 2000; 85: 44074410.
  • 29
    Ceresini G, Morganti S, Rebecchi I et al. A one-year follow-up on the effects of raloxifene on thyroid function in postmenopausal women. Menopause 2004; 11: 176179.
  • 30
    Cevik R, Em S, Gur A, Nas K, Sarac AJ, Colpan L. Sex and thyroid hormone status in women with rheumatoid arthritis: Are there any effects of menopausal state and disease activity on these hormones? Int. J. Clin. Pract. 2004; 58: 327332.
  • 31
    Pae CU, Mandelli L, Kim TS et al. Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: A pilot study on differential effects of sex hormones on antidepressant effects. Biomed. Pharmacother. In press.
  • 32
    Zanardi R, Cusin C, Rossini D, De Ronchi D, Serretti A. Comparison of response to fluvoxamine in nondemented elderly compared to younger patients affected by major depression. J. Clin. Psychopharmacol. 2003; 23: 535539.
  • 33
    Mandelli L, Serretti A, Zanardi R et al. Antidepressant response in the elderly. Psychiatry Res. 2007; 152: 3744.
  • 34
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. American Psychiatric Association, Washington, DC, 1994.
  • 35
    McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992; 14: 103115.
  • 36
    Baloch Z, Carayon P, Conte-Devolx B et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13: 3126.
  • 37
    Han OS, Ahn JH, Song SH. Development of Korean version of structured clinical interview schedule for DSM-IV axis I disorder: Interrater reliability. J. Korean Neuropsychiatr. Assoc. 2000; 39: 362372.
  • 38
    Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J. Clin. Psychopharmacol. 1990; 10: 96104.
  • 39
    Lee JS, Bae SO, Ahn YM. Validity and reliability of the Korean version of the Hamilton depression rating scale (K-HDRS). J. Korean Neuropsychiatr. Assoc. 2004; 44: 456465.
  • 40
    Ahn YM, Lee KY, Lee JS. A validation study of the Korean-version of the Montgomery- Asberg depression rating scale. J. Korean Neuropsychiatr. Assoc. 2005; 44: 466477.
  • 41
    Guy W. ECDEU Assessment Manual for Psychopharmacology: Revised. NIMH, Rockville, MD, 1976.
  • 42
    Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br. J. Clin. Psychol. 1982; 21: 116.
  • 43
    Doufas AG, Mastorakos G. The hypothalamic-pituitary-thyroid axis and the female reproductive system. Ann. N. Y. Acad. Sci. 2000; 900: 6576.
  • 44
    Chakrabarti S, Malhotra MD. Thyroid hormones in treatment of mood disorders. Indian J. Med. Sci. 2001; 55: 501507.
  • 45
    Chomard P, Vernhes G, Autissier N, Debry G. Serum concentrations of total and free thyroid hormones in moderately obese women during a six-week slimming cure. Eur. J. Clin. Nutr. 1988; 42: 285293.